Compare AAOI & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAOI | BCRX |
|---|---|---|
| Founded | 1997 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2013 | 1994 |
| Metric | AAOI | BCRX |
|---|---|---|
| Price | $26.04 | $7.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $27.40 | $19.00 |
| AVG Volume (30 Days) | ★ 5.6M | 4.0M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $421,712,000.00 | ★ $599,816,000.00 |
| Revenue This Year | $96.63 | $41.57 |
| Revenue Next Year | $62.31 | $6.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 101.25 | 45.38 |
| 52 Week Low | $9.71 | $6.00 |
| 52 Week High | $44.50 | $11.31 |
| Indicator | AAOI | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 53.63 |
| Support Level | $18.50 | $7.02 |
| Resistance Level | $27.29 | $7.23 |
| Average True Range (ATR) | 2.12 | 0.25 |
| MACD | 0.66 | 0.03 |
| Stochastic Oscillator | 83.62 | 81.30 |
Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.